Overview
Status
Active
Registry date
2019-01-23
Share capital
20,000.00 PLN
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 245 days for 2024).
- 2025not filed
- 202417/03/2026
- 202321/10/2024
- 202227/12/2023
- 202111/01/2023
- 202027/04/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Agnieszka Łopatka – President of the Management Board
Bartosz Skrendo – Attorney-in-fact (sole)
Manner of representation
The declarations of will on behalf of the company require the joint action of two members of the management board or one member of the management board together with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Tomasz Stanisław Bernatage 58 | 25 | $1,350.62 | 25% |
Agnieszka Łopatkaage 38 | 25 | $1,350.62 | 25% |
Teresa Piotrowskaage 70 | 25 | $1,350.62 | 25% |
Bartosz Skrendoage 34 | 25 | $1,350.62 | 25% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2019-02-01.
82 1600 1462 1726 6349 7000 0001
Debt
No entries in the National Debtors Register (KRZ).
Public aid
5 public aid cases recorded, with a total value of $38,309.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 17, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $12,070$12,070 | Marszałek Zachodniopomorski | |
| Aug 12, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $3,558$3,558 | Polska Agencja Inwestycji I Handlu S.A. | |
| Jun 10, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Szczecin |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Read-GeneS.A. | $2,163,474.84 | read-gene.com | ||
| Centrum Innowacji i Wdrożeń Bio-Inwestsp. z o.o. | $1,262,872.91 | bio-inwest.pl | ||
| Centrum Badań Weterynaryjnych Vetcomplexsp. z o.o. | $255,522.81 | vetcomplex.pl | ||
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | ||
| Luna Laboratorysp. z o.o. | $61,894.23 | lunalab.pl | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Immbionicsp. z o.o. | $31,756.23 | immbionic.com.pl | ||
| Detoxedsp. z o.o. | $11,972.37 | detoxed.pl | ||
| Poltisssp. z o.o. | $3,843.72 | poltiss.com | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com |
FAQ
The main business activity of Allegen focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on January 23, 2019.
The headquarters is located at: ul. Cukrowa 12, 71-004 Szczecin.
The management board consists of: Agnieszka Łopatka (President of the Management Board).
The share capital of the company is PLN 20,000 (approx. $5,402).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-04-10